DCC-2812
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for DCC-2812, covering 2026-04-21 to 2026-04-21. Get the full timeline:
Most recent: Clinical Trial Update: Study of DCC-2812 in Participants With Advanced Genitourinary Cancers [Phase 1]